Warning: Undefined array key "HTTP_ACCEPT_LANGUAGE" in /home/u596154002/domains/usbusinessreviews.com/public_html/wp-includes/load.php on line 2057

Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the rank-math domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /home/u596154002/domains/usbusinessreviews.com/public_html/wp-includes/functions.php on line 6114
U.S. experts discuss COVID boosters for the fall and beyond - Best Business Review Site 2024

U.S. experts discuss COVID boosters for the fall and beyond

[ad_1]

While many Americans are trying to move on with their lives after two years of the COVID-19 pandemic, U.S. health officials are debating the best way to use vaccines to stay ahead of the coronavirus.

A panel of U.S. vaccine experts was meeting Wednesday to discuss key questions for future COVID-19 booster campaigns. The Food and Drug Administration’s vaccine advisers won’t make any binding decisions during the virtual meeting, but their advice could shape the government’s approach for years to come.

FDA vaccine chief Dr. Peter Marks told reporters last week that it wouldn’t be surprising if the agency authorized another booster dose in the fall to protect most Americans against the latest coronavirus mutations. He opened Wednesday’s meeting by cautioning that waning vaccine protection, new variants and colder weather later this year could raise the risk of more surges.

“All that taken together makes us conclude that a general discussion of booster vaccination against COVID-19 is warranted at this time so that we can potentially intervene,” Marks said.

Not a Modern Healthcare subscriber? Sign up today.

Some of the key questions for the panel:

How should the U.S. decide when to launch future rounds of booster shots? Who should get them?

Last week, the FDA authorized an extra Pfizer or Moderna shot for anyone 50 or older and for some younger people with severely weakened immune systems. It’s an effort to get ahead of another possible surge.

Only about half of Americans eligible for a third shot have gotten one. And some independent experts disagree about the need for even that additional protection in healthy individuals, due to limited evidence of the benefit or how long it might last.

The last U.S. wave was driven by the omicron variant. During that surge, two doses were nearly 80% effective against needing a ventilator or death — and a booster pushed that protection to 94%, federal scientists have reported. COVID-19 cases have dropped to low levels in the U.S., but health officials are warily watching an omicron sibling that now accounts for most cases.

Read more: 
Who really needs a second COVID booster? Here’s what to know

FDA OKs another Pfizer, Moderna COVID booster for 50 and up

What’s the process for updating vaccines to address new variants?

All the COVID-19 vaccines now used in the U.S. are based on the original coronavirus version that emerged in late 2019. Updating the vaccines will be a complex task, requiring coordination between the FDA, manufacturers and global health authorities.

The process for updating annual flu vaccines offers one possible model for dealing with mutations. The FDA panel is expected to discuss the strengths and weakness of adopting such an approach.

Twice a year, World Health Organization experts recommend updates to flu vaccines to target emerging strains. The FDA then brings those recommendations to its own vaccine panel, which votes on whether they make sense for the U.S., setting the stage for manufacturers to tweak their shots and begin mass production.

But COVID-19 hasn’t yet fallen into a predictable pattern like the flu. And vaccine manufacturers will likely need more time to conduct additional studies of their COVID-19 vaccines, which don’t have the same decades-long record of safety and effectiveness as flu shots.

[ad_2]

Source link

slot gacor slot gacor togel macau slot hoki bandar togel slot dana slot mahjong link slot link slot777 slot gampang maxwin slot hoki slot mahjong slot maxwin slot mpo slot777 slot toto slot toto situs toto toto slot situs toto situs toto situs toto situs toto slot88 toto slot slot gacor thailand slot bet receh situs toto situs toto slot toto slot situs toto situs toto situs toto situs togel macau toto slot slot demo slot pulsa slot pragmatic situs toto deposit dana 10k surga slot toto slot link situs toto situs toto slot situs toto situs toto slot777 slot gacor situs toto slot slot pulsa 10k toto togel situs toto slot situs toto slot gacor terpercaya slot dana slot gacor pay4d agen sbobet kedai168 kedai168 deposit pulsa situs toto slot pulsa situs toto slot pulsa situs toto situs toto situs toto slot dana toto slot situs toto slot pulsa toto slot situs toto slot pulsa situs toto situs toto situs toto toto slot toto slot slot toto akun pro maxwin situs toto slot gacor maxwin slot gacor maxwin situs toto slot slot depo 10k toto slot toto slot situs toto situs toto toto slot toto slot toto slot toto togel slot toto togel situs toto situs toto toto slot slot gacor slot gacor slot gacor situs toto situs toto cytotec toto slot situs toto situs toto toto slot situs toto situs toto slot gacor maxwin slot gacor maxwin link slot 10k slot gacor maxwin slot gacor slot pulsa situs slot 10k slot 10k toto slot toto slot situs toto situs toto situs toto bandar togel 4d toto slot toto slot